SCHEMBL3786929

SCHEMBL3786929

CS(=O)(=O)OCC1Cc2ccnc3ccc(=O)n1c23

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3428409 0.79 GSK3B (0.33)
SCHEMBL3779375 0.79 HTR1A (0.30)
SCHEMBL3783455 0.78
SCHEMBL3428015 0.78 HTR1A (0.41)
SCHEMBL1712253 0.72 KCNH2 (0.31)
SCHEMBL2285886 0.72 KCNH2 (0.31)
SCHEMBL3607637 0.71 KCNH2 (0.32)
SCHEMBL3615899 0.71 KCNH2 (0.33)
SCHEMBL3615945 0.71
SCHEMBL3432745 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257551-B1 AZATRICYCLIC ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2013-04-10 EP disclosed
US-8349828-B2 Azatricyclic antibiotic compounds ACTELION PHARMACEUTICALS LTD. (CH) 2013-01-08 US disclosed
US-20100331318-A1 AZATRICYCLIC ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD. (CH) 2010-12-30 US disclosed